Patents matching “air”

US 9827268

Curable calcium phosphate composition for biological hard tissue repair, bone repair material, and various dental materials

KURARAY NORITAKE DENTAL INC. · Granted Nov 28, 2017 · Expires Nov 23, 2037

US 9801865

Materials and methods for diagnosis, prevention and/or treatment of stress disorders and conditions associated with abeta peptide aggregation

The United States of America as represented by the Department of Veteran Affairs · Granted Oct 31, 2017 · Expires Oct 26, 2037

US 9795661

TH1/TH2 polarizing vaccines

United States of America as represented by the Secretary of the Air Force · Granted Oct 24, 2017 · Expires Oct 19, 2037

US 9789162

Systemic and local ex vivo gene therapy of the skeleton

The United States of America as represented by the Department of Veteran Affairs · Granted Oct 17, 2017 · Expires Oct 12, 2037

US 9731037

Scanning suspension comprising a particle with a diameter of at least 1 micrometer

Universitair Medisch Centrum Utrecht · Granted Aug 15, 2017 · Expires Aug 10, 2037

US 9713600

Method for treating metabolic syndrome

United States of America as represented by the Secretary of the Air Force · Granted Jul 25, 2017 · Expires Jul 20, 2037

US 9707199

Heptadecanoic acid supplement to human diet

United States of America as represented by the Secretary of the Air Force · Granted Jul 18, 2017 · Expires Jul 13, 2037

US 9701740

Cell-penetrating anti-DNA antibodies and uses thereof inhibit DNA repair

THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Jul 11, 2017 · Expires Jul 6, 2037

US 9694062

Plasmodium falciparum sporozoite and liver stage antigens

United States of America as represented by the Secretary of the Air Force · Granted Jul 4, 2017 · Expires Jun 29, 2037

US 9687461

Method for detecting risk factor for metabolic syndrome or hyperferritinemia

United States of America as represented by the Secretary of the Air Force · Granted Jun 27, 2017 · Expires Jun 22, 2037

US 9662306

Compositions and methods for diagnosis and treatment of metabolic syndrome

United States of America as represented by the Secretary of the Air Force · Granted May 30, 2017 · Expires May 25, 2037

US 9645147

Recombinant polypeptide construct comprising Plasmodium falciparum circumsporozoite protein HLA class I restricted T-cell epitopes

United States of America as represented by the Secretary of the Air Force · Granted May 9, 2017 · Expires May 4, 2037

US 9636515

Method of repairing age and disease immune dysfunction and cellular senescence with lymphoid stem cells and then re-applying those for therapeutic use

Advanced Neuroregenerative Therapies, LLC. · Granted May 2, 2017 · Expires Apr 27, 2037

US 9598441

Therapeutic compounds and methods

The United States of America as represented by the Department of Veteran Affairs · Granted Mar 21, 2017 · Expires Mar 16, 2037

US 9592265

Modulation of oxidative stress, inflammation, and impaired insulin sensitivity with grape seed extract

The Regents of the University of California · Granted Mar 14, 2017 · Expires Mar 9, 2037

US 9592256

Compositions and methods for tissue repair with extracellular matrices

The Regents of the University of California · Granted Mar 14, 2017 · Expires Mar 9, 2037

US 9561206

Use of heptadecanoic acid (C17:0) to detect risk of and treat hyperferritinemia and metabolic syndrome

United States of America as represented by the Secretary of the Air Force · Granted Feb 7, 2017 · Expires Feb 2, 2037

US 9546151

VMAT inhibitory compounds

The United States of America as represented by the Department of Veteran Affairs · Granted Jan 17, 2017 · Expires Jan 12, 2037

US 9534007

Methods and compositions for treatment of cyanide and hydrogen sulfide toxicity

United States of America as represented by the Secretary of the Air Force · Granted Jan 3, 2017 · Expires Dec 29, 2036

US 9523079

Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes

The Board of Regents of the University of Texas System · Granted Dec 20, 2016 · Expires Dec 15, 2036

US 9513289

Isoform-selective inhibitors and activators of PDE3 cyclic nucleotide phosphodiesterases

The United Sates of America, as Represented by the Department of Veterans Affairs · Granted Dec 6, 2016 · Expires Dec 1, 2036

US 9511075

Targeting NCCA-ATP channel for organ protection following ischemic episode

The United States of America as Represented by the Dept. of Veterans Affairs · Granted Dec 6, 2016 · Expires Dec 1, 2036

US 9506922

Methods for producing an immune response to tuberculosis

United States Government as represented by the Department of Veterans Affairs · Granted Nov 29, 2016 · Expires Nov 24, 2036

US 9493482

Compounds and methods for preventing or treating sensory hair cell death

Oricula Therapeutics LLC · Granted Nov 15, 2016 · Expires Nov 10, 2036